NCT02897375View on ClinicalTrials.gov

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

October 24, 2016

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast CancerStage IIIA Non-Small Cell Lung CancerStage IIIB Breast CancerStage IIIB Non-Small Cell Lung CancerStage IIIC Breast CancerStage IV Breast CancerStage IV Non-Small Cell Lung CancerStage IVA Pancreatic CancerStage IVB Pancreatic CancerSarcomaColorectal CancerHead and Neck CancerCancer of Unknown PrimaryBladder CancerOvarian Cancer
Interventions
DRUG

Carboplatin

Given IV

DRUG

Cisplatin

Given IV

DRUG

Palbociclib

Given PO

Trial Locations (1)

30322

Emory University/Winship Cancer Institute, Atlanta

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER